載入...
Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial
PURPOSE: (18)F-Labelled fluorodeoxyglucose (FDG) can detect early changes in tumour metabolism and may be a useful quantitative imaging biomarker (QIB) for prediction of disease stabilization, response and duration of progression-free survival (PFS). Standardization of imaging procedures is a prereq...
Na minha lista:
| 發表在: | Eur J Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Berlin Heidelberg
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4382532/ https://ncbi.nlm.nih.gov/pubmed/25711176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-015-3002-0 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|